ALNY vs ENVX · P/E 76, rev $1.29B vs rev $16.6M
Alnylam Pharmaceuticals Inc (ALNY) versus Enovix Corp (ENVX) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Enovix Corp (ENVX) is a electrical equipment & parts company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported ENVX revenue for 2026-07-05 was $16.6M. Net income was -$81.3M. ENVX currently screens at market cap $2.79B.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. ENVX currently screens at market cap $2.79B.
Not investment advice. Open the ALNY and ENVX stock pages for the full models.
Not investment advice.